000906021 001__ 906021
000906021 005__ 20230113085400.0
000906021 0247_ $$2doi$$a10.3233/JAD-210261
000906021 0247_ $$2ISSN$$a1387-2877
000906021 0247_ $$2ISSN$$a1875-8908
000906021 0247_ $$2Handle$$a2128/33066
000906021 0247_ $$2pmid$$a35068451
000906021 0247_ $$2WOS$$aWOS:000768536700025
000906021 037__ $$aFZJ-2022-01186
000906021 082__ $$a610
000906021 1001_ $$0P:(DE-Juel1)167565$$aRichter, Nils$$b0$$eCorresponding author$$ufzj
000906021 245__ $$aAge and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer’s Disease
000906021 260__ $$aAmsterdam$$bIOS Press$$c2022
000906021 3367_ $$2DRIVER$$aarticle
000906021 3367_ $$2DataCite$$aOutput Types/Journal article
000906021 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1670921060_17645
000906021 3367_ $$2BibTeX$$aARTICLE
000906021 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000906021 3367_ $$00$$2EndNote$$aJournal Article
000906021 520__ $$aAbstract.Background: Early and severe neuronal loss in the cholinergic basal forebrain is observed in Alzheimer’s disease (AD). Todate, cholinomimetics play a central role in the symptomatic treatment of AD dementia. Although basic research indicatesthat a cholinergic deficit is present in AD before dementia, the efficacy of cholinomimetics in mild cognitive impairment(MCI) remains controversial. Predictors of cholinergic impairment could guide individualized therapy.Objective: To investigate if the extent of the cholinergic deficit, measured using positron emission tomography (PET) and thetracer 11C-N-methyl-4-piperidyl acetate (MP4A), could be predicted from the volume of cholinergic basal forebrain nucleiin non-demented AD patients.Methods: Seventeen patients with a high likelihood of MCI due to AD and 18 age-matched cognitively healthy adultsunderwent MRI-scanning. Basal forebrain volume was assessed using voxel-based morphometry and a cytoarchitectonicatlas of cholinergic nuclei. Cortical acetylcholinesterase (AChE) activity was measured using MP4A-PET.Results: Cortical AChE activity and nucleus basalis of Meynert (Ch4 area) volume were significantly decreased in MCI.The extent of the cholinergic deficit varied considerably across patients. Greater volumes of anterior basal forebrain nuclei(Ch1/2 area) and younger age (Spearman’s rho(17) = –0.596, 95%-CI [–0.905, –0.119] and 0.593, 95%-CI [0.092, 0.863]))were associated with a greater cholinergic deficit.Conclusion: Data suggest that less atrophy of the Ch1/2 area and younger age are associated with a more significant cholinergicdeficit in MCI due to AD. Further investigations are warranted to determine if the individual response to cholinomimeticscan be inferred from these measures.Keywords: Acetylcholinesterase, aging, MP4A, nucleus basalis of Meynert, positron emission tomography
000906021 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000906021 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000906021 7001_ $$0P:(DE-HGF)0$$aDavid, Lara-Sophia$$b1
000906021 7001_ $$0P:(DE-HGF)0$$aGrothe, Michel J.$$b2
000906021 7001_ $$0P:(DE-HGF)0$$aTeipel, Stefan$$b3
000906021 7001_ $$0P:(DE-HGF)0$$aDietlein, Markus$$b4
000906021 7001_ $$0P:(DE-HGF)0$$aTittgemeyer, Marc$$b5
000906021 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b6$$ufzj
000906021 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon R.$$b7$$ufzj
000906021 7001_ $$0P:(DE-HGF)0$$aOnur, Oezguer A.$$b8
000906021 7001_ $$0P:(DE-Juel1)131730$$aKukolja, Juraj$$b9
000906021 773__ $$0PERI:(DE-600)2070772-1$$a10.3233/JAD-210261$$gp. 1 - 16$$n1$$p425-440$$tJournal of Alzheimer's disease$$v86$$x1387-2877$$y2022
000906021 8564_ $$uhttps://juser.fz-juelich.de/record/906021/files/Invoice_P20220240.pdf
000906021 8564_ $$uhttps://juser.fz-juelich.de/record/906021/files/POSTPRINT.pdf$$yOpenAccess
000906021 8564_ $$uhttps://juser.fz-juelich.de/record/906021/files/jad_2022_86-1_jad-86-1-jad210261_jad-86-jad210261.pdf$$yRestricted
000906021 8767_ $$8P20220240$$92022-01-25$$d2022-02-02$$eHybrid-OA$$jZahlung erfolgt$$zBelegnr. 1200176982
000906021 909CO $$ooai:juser.fz-juelich.de:906021$$pdnbdelivery$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire
000906021 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)167565$$aForschungszentrum Jülich$$b0$$kFZJ
000906021 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b6$$kFZJ
000906021 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b7$$kFZJ
000906021 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000906021 9141_ $$y2022
000906021 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ ALZHEIMERS DIS : 2021$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000906021 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-18
000906021 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-18
000906021 920__ $$lyes
000906021 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000906021 980__ $$ajournal
000906021 980__ $$aVDB
000906021 980__ $$aUNRESTRICTED
000906021 980__ $$aI:(DE-Juel1)INM-3-20090406
000906021 980__ $$aAPC
000906021 9801_ $$aAPC
000906021 9801_ $$aFullTexts